CAPTRUST Financial Advisors
TELO icon

CAPTRUST Financial Advisors’s Telomir Pharmaceuticals TELO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.5K Buy
+51,194
New +$66.7K ﹤0.01% 3098

Other funds holding TELO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

CAPTRUST Financial Advisors's TELO Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Telomir Pharmaceuticals (TELO) in Q2 2026: 51,194 shares worth $65.5K. The stake represents ﹤0.01% of the portfolio and ranks #3098 among its holdings.

24 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • CAPTRUST Financial Advisors held 51,194 shares of Telomir Pharmaceuticals worth $65.5K as of Q2 2026.
  • Telomir Pharmaceuticals was a new CAPTRUST Financial Advisors position in Q2 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3098 holding.
  • 24 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.